Pharmacological Blockade of Serotonin 5-HT₇ Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission

• Pascal Bonaventure ,

  * E-mail: Pbonave1@its.jnj.com

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Leah Aluisio,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• James Shoblock,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Jamin D. Boggs,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Ian C. Fraser,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Brian Lord,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Timothy W. Lovenberg,

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯
• Ruggero Galici

  Current address: Bristol-Myers Squibb, Wallingford, Connecticut, United States of America

  Affiliation Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, California, United States of America

  ⨯